Search

everythinglearnresearchcommunity

for

Search:↓

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

A blood pressure drug, diltiazem, may also help treat influenza.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Stem cell therapy may help treat tough hair loss cases.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Researchers isolated a new type of stem cell from mouse skin that can renew itself and turn into multiple cell types.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Early diagnosis and treatment of TPP can prevent complications.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.